Brightgene Bio-medical Technology Co., Ltd.

This study compares two versions of an experimental injection called BGM0504 to see if they work the same way in the body. It involves 144 overweight or obese adults aged 18-55. Participants receive a single dose, and researchers measure drug levels and monitor for side effects.

This early-stage trial tests an experimental weight loss pill called BGM0504 in 75 healthy and overweight or obese Chinese adults. Participants will receive either the drug or a placebo to check for side effects and measure weight changes over 8 weeks. The goal is to see if the d…

This early-stage trial is testing a new drug called BGM1812, given as an injection under the skin, to see if it is safe and how it works in the body. The study involves 60 healthy adults who are overweight or obese. Researchers will measure weight changes and monitor for any side…

This phase 3 trial compares a new injectable drug, BGM0504, to the established drug semaglutide (Ozempic) in 477 adults with type 2 diabetes. All participants also take metformin. The study measures how well each drug controls blood sugar and weight over 24 weeks. The goal is to …

This Phase 2 trial compares a new drug, BGM0504, to the existing weight-loss drug tirzepatide in 90 adults with obesity (BMI 35-45) who do not have diabetes. Participants will receive one of the two drugs for 26 weeks to see which leads to greater weight loss and improvements in …

This early-stage trial tests an experimental pill called BGM0504 in 80 non-diabetic adults who are overweight or obese. Participants receive either the drug or a placebo daily for several weeks. Researchers will check how the drug moves through the body, its safety, and whether i…

This early-stage study tests a new drug called BGM1812 in 60 healthy or overweight/obese Chinese adults who do not have diabetes. The main goal is to check the drug's safety and how the body processes it. Participants receive either the drug or a placebo by injection, and researc…

This early-stage study looks at how a high-fat meal and different drinking conditions change the way a new drug (BGM0504) is processed in the body. It involves 144 healthy Chinese adults aged 18 to 55. The goal is to understand the best way to take the drug for future trials, not…